SAN DIEGO, Oct. 10, 2017 /PRNewswire/ -- MDRejuvena, Inc., a private company focused on skin health, has launched the
MDRejuvena has obtained an exclusive, worldwide license to the patents, trademarks and know-how for Vivatia. When Vivatia was previously marketed by PrecisionMD, prior to its acquisition by Valeant Pharmaceuticals, the product line enjoyed strong consumer acceptance and had thousands of customers in the professional market.
Hyperpigmentation is a major skincare problem around the world. It results from a number of causes, including photodamage from the sun, pregnancy, hormonal changes, inflammation and cosmetic procedures like laser treatment and chemical peels. It can also be caused by several skin conditions, such as melasma and post-inflammatory hyperpigmentation (PIH).
"We are very excited to bring the Vivatia product line back to the professional market. Vivatia not only fills a significant void in the market place and within our current product portfolio, but it also provides us with another patented technology platform in which to further expand our already robust product pipeline," said Randy Kriech, President and CEO of MDRejuvena. "When Vivatia was previously on the market, it was well accepted by physicians and patients because of its effectiveness."
David F. Hale, Executive Chairman of MDRejuvena, stated, "We believe the launch of Vivatia will add significantly to MDRejuvena's product offering and revenues. The market demand for skin lightening products represents the largest skincare market worldwide and continues to show significant growth."
Vivatia is a skin brightening system that includes three components:
MDRejuvena is a private company focused on the licensing, development and commercialization of products for skin health and beauty for the professional market in the U.S. and internationally. Further information on the company may be found on www.mdrejuvena.com.
MDREJUVENA is a trademark of MDRejuvena, Inc.
VIVATIA is a trademark of Shamroc, Inc.
View original content:http://www.prnewswire.com/news-releases/mdrejuvena-inc-announces-us-launch-of-the-proprietary-and-patented-vivatia-skin-lightening-product-line-300533725.html
SOURCE MDRejuvena, Inc.
Subscribe to our Free Newsletters!
Parkinson's disease (PD) is a chronic and progressive disease of the nervous system, causing ...
Iridectomy is a procedure in which an opening is made in the iris of the eye.
Hand hygiene is a simple and affordable technique to prevent infections.View All